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Background: Developing countries frequently use hospital accreditation to guarantee quality and patient safety.
However, implementation of accreditation standards is demanding on organisations. Furthermore, the empirical
literature on the benefits of accreditation is sparse and this is the first empirical interrupted time series analysis
designed to examine the impact of healthcare accreditation on hospital quality measures.
Methods: The study was conducted in a 150-bed multispecialty hospital in Abu Dhabi, United Arab Emirates. The
quality performance outcomes were observed over a 48 month period. The quality performance differences were
compared across monthly intervals between two time segments, 1 year pre- accreditation (2009) and 3 years
post-accreditation (2010, 2011 and 2012) for the twenty-seven quality measures. The principal data source was a
random sample of 12,000 patient records drawn from a population of 50,000 during the study period (January 2009 to
December 2012). Each month (during the study period), a simple random sample of 24 percent of patient records was
selected and audited, resulting in 324,000 observations. The measures (structure, process and outcome) are related to
important dimensions of quality and patient safety.
Results: The study findings showed that preparation for the accreditation survey results in significant improvement as
74% of the measures had a significant positive pre-accreditation slope. Accreditation had a larger significant negative
effect (48% of measures) than a positive effect (4%) on the post accreditation slope of performance. Similarly,
accreditation had a larger significant negative change in level (26%) than a positive change in level (7%) after the
accreditation survey. Moreover, accreditation had no significant impact on 11 out of the 27 measures. However,
there is residual benefit from accreditation three years later with performance maintained at approximately 90%,
which is 20 percentage points higher than the baseline level in 2009.
Conclusions: Although there is a transient drop in performance immediately after the survey, this study shows
that the improvement achieved from accreditation is maintained during the three year accreditation cycle.
Keywords: Accreditation, Joint Commission International, Healthcare quality measures, Interrupted time series analysisBackground
Introduction
The frequency and magnitude of medical errors is gaining
public focus [1]. In response to concerns about quality, es-
calating costs and government regulated accountability
standards, healthcare leaders are seeking scientific
methods for improving healthcare quality in hospitals.
Optimal solutions, however, are proving to be elusive.
Although several concepts, methodologies and tools
have been postulated to advance quality and patient* Correspondence: Subashnie_d@hotmail.com
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compelling evidence of their impact and effectiveness,
none more so than the all-encompassing strategy of ac-
creditation [5-10].
Braithwaite, J. et al. [11] have argued that, “empirical
evidence to sustain many claims about the benefits of
accreditation is currently lacking”. Nevertheless, many
countries, including the UAE, are frequently utilizing ac-
creditation as a tool for government regulation to guaran-
tee quality of care and improve patient safety. However,
implementation of accreditation standards is demanding
on individuals and organisations [12]. In addition, the the-
oretical and empirical literature on accreditation ised Central.; licensee BioMed Central. This is an Open Access article distributed
tribution License (http://creativecommons.org/licenses/by/2.0), which permits
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Middle East.
Previous research on the impact of healthcare accredit-
ation shows inconsistent results [13,14]. Accordingly,
there has been an extensive call in the healthcare litera-
ture for an assessment of such external accreditation
systems to produce rigorous evaluations of their impact
[9,15-18]. In this paper we report on an interrupted
time series analysis of the impact of accreditation over
a 4 year period (before and after accreditation) of a
150-bed hospital in Abu Dhabi.
International accreditation
Joint Commission International (JCI) is a not-for-profit
affiliate formed by The Joint Commission (TJC) to provide
leadership in healthcare accreditation and quality im-
provement for organisations outside the United States.
By 2013, JCI had accredited 500 healthcare organisations
internationally [19]. A hospital seeking to obtain JCI ac-
creditation is visited every three years by a survey team
that observes hospital operations, conducts interviews,
and reviews medical documentation for compliance with a
set of standards. The goal of the survey is to evaluate care,
organisational processes and to provide education with
the objective of promoting continual improvement for the
organisation under survey.
Methods
The impact of accreditation has been researched adopting
a variety of methodologies and research designs. There is
a lack of rigorous research including the methodological
challenges of measuring outcomes and attributing causal-
ity to these complex, changing, long-term social interven-
tions to healthcare organisations [9]. Researchers have
wrestled with a range of methodological issues, including
research designs, selection bias, quality measurement, and
the problems of evaluating outcomes. Most studies have
used cross-sectional designs and/or comparative statistical
analysis of data at two points in time [8,20-22]. Due to the
dynamic nature of accreditation, such methodologies
can only identify statistical associations between variables
but cannot alone establish causality [23]. Instead, a dy-
namic statistical analysis technique is needed to draw
causal inferences about the influence of accreditation on
clinical quality, over time [9]. The use of a time series
framework, in this research, directly addresses this issue.
A longitudinal study enables causal relationships between
variables to be determined. Furthermore, research projects
that did demonstrate improvements in quality measures
could not be generalized to acute care settings as they
focused on a specific measures (e.g. AMI measures),
types of services (e.g. cardiology) or organisations (e.g.
teaching hospitals) [20-24]. This study is the first em-
pirical interrupted time series analysis of accreditationdesigned to examine the impact of accreditation on hos-
pital quality measures. No previous studies have used this
methodology as it is difficult to maintain a controlled en-
vironment during the period of study. However the hos-
pital analyzed did not undergo any significant
organisational changes between 2009 and 2012. Thus both
the leadership, organisational structure and the scope of
services remained the same. Furthermore, the 27 qual-
ity measures selected reflect structures, processes and
outcomes of care.
Study design
Interrupted time series analysis, distinguishes between
the effects of time from that of the intervention and is
the most powerful, quasi-experimental design to evaluate
longitudinal effects of such time-limited interventions
[25,26]. The interruption splits the time series into pre-
intervention and post- intervention (accreditation) seg-
ments so that segmented regression analysis of interrupted
time series data permits the researcher to statistically
evaluate the impact of an intervention on an outcome
variable, both immediately and long-term; and the extent
to which factors other than the intervention explain the
change. The choice of the beginning (2009) and end of
each segment (2012) is linked to the start of the interven-
tion (JCI accreditation occurred in December 2009). In
this study, two parameters were used to define each seg-
ment of the time series: level and trend. The level is the
value of the series at the beginning of a given time interval
(i.e. the Y intercept for the first segment, and the value im-
mediately following a change point or intervention). The
trend is the rate of change of a variable (the slope) during
a segment. Segmented regression analysis enables iden-
tification of the level and trend in the pre-accreditation
(pre-intervention) segment and changes in level and
trend after accreditation (post-intervention).
Study population
The study was conducted in the private 150-bed, multi-
specialty, acute care hospital in Abu Dhabi, UAE. The
annual in-patient census was 15,000. The hospital treats
approximately half a million ambulatory care patients per
year. The scope of healthcare services is provided to all
patient age groups, nationalities and payment types.
Data source and study variables for clinical quality
measures
The outcome measures for the time series analysis incor-
porated clinical quality measures, including mortality rates
etc. and were expressed as percentages, proportions or
rates. These performance differences were compared
across monthly intervals between two time segments,
1 year pre-accreditation (2009) and 3 years post-
accreditation (2010, 2011 and 2012) for the selected
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was a random sample of 12,000 patient records drawn
from a population of 50,000 during the study period
(January 2009 to December 2012), resulting in 324,000
observations /data points. Slovin’s formula was used to
calculate the sample size per month based on a 95% confi-
dence interval from an average monthly in-patient census
of 1,500 patients. Each month (during the entire study
period), a simple random sample of 24% of patient records
were selected and audited from the monthly population.
The first criterion for measure selection was that all
variables must be directly linked to a JCI standard. Second,
the measures should reflect high priority areas that willTable 1 Quality measure descriptions
Dimension of measurement Measures
Patient Assessment Y1 Initial medical assessme
Y2 Initial nursing assessme
Y3 Pain assessment form c
Y4 Percentage of complet
Laboratory Safety Y5 Monitor the timeliness
lab results
Y6 The turnaround time o
Surgical Procedures Y7 Completion of surgical
Y8 Percentage of operatin
Y9 Unplanned return to O
Medication error use and near-misses Y10 Reported medication e
Anaesthesia and Sedation Use Y11 Completed anaesthesia
Y12 Completed Modified A
Y13 Completed pre-anaesth
Y14 Completion of anaesth
Y15 Percentage of complet
anaesthesia
Y16 Effective communicatio
explained to patients
Availability, Content and Use of Patient
Records
Y17 Percentage of typed po
Infection Control, Surveillance and Reporting Y18 Hospital acquired meth
Y19 Healthcare associated i
Y20 Surgical site infection ra
Reporting of Activities as Required by Law and
Regulation
Y21 Mortality rate
International Patient Safety Goals Y22 Monitoring correct site
Y23 Monitoring compliance
Y24 Screening of patient fal
Y25 Overall hospital hand h
Y26 Patient fall rate
Y27 Fall risk assessment and
Source: Subashnie Devkaran.affect outcomes of care. Third, the measures have a pre-
defined profile which is based on: the process, procedure,
or outcome to be measured; the availability of science or
evidence supporting the measure; the dimension of quality
that is captured by the measure, e.g. timeliness etc.; and
the frequency of measurement. Finally, all measures are ap-
plicable to all patients in the hospital and are not specific
to a specialty or disease. An internal data validation process
is in place within the hospital included: re-collecting the
data by second person not involved in the original data
collection; using a statistically valid sample of records,
cases or other data; comparing the original data with
the re-collected data; calculating the accuracy byValue
nt done within 24 hours of admission Percentage
nt within 24 hr. of admission Percentage
ompleted 100% per month Percentage
ed pain reassessment Percentage
of complete blood count (cbc) as routine (in hours)
f troponin lab results (in minutes)
invasive procedure consent Percentage
g room (or) cancellation of elective surgery Percentage
R within 48 hours Percentage
rror Per 1000
prescriptions
, moderate and deep sedation consent forms Percentage
ldrete Scores (Pre, Post, Discharge) Percentage
esia assessments Percentage
esia care plan Percentage
ed assessment of patient who received Percentage
n of risk, benefit and alternatives of anaesthesia Percentage
st-operative report completed with 48 hours Percentage
icillin resistant staph aureus (MRSA) rate Per 1000 Admissions
nfection hospital-wide per 1000 patient
days
te Percentage
Percentage
marking Percentage
with the time-out procedure Percentage
l risk Percentage
ygiene compliance rate Percentage
Per 1000 patient days
reassessment Percentage
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by the total number of data elements and multiplying
that total by 100. A 90% accuracy level is considered an
acceptable benchmark. When the data elements dif-
fered, the reasons were noted (for example, unclear
data definitions) and corrective actions were taken. A new
sample was collected after all corrective actions have
been implemented to ensure the actions resulted in the
desired accuracy level.
Ethics statement
The study was approved by the AN Hospital Ethics
Committee. Furthermore, no identifiable human data were
used for this study. The anonymous data set in the study
was only accessible to the researchers thus, patient privacy
was ensured.
Data analysis of the clinical quality measures
Interrupted time series analysis
Segmented regression models fit a least squares regres-
sion line to each segment of the independent variable,
time, and thus assume a linear relationship between time
and the outcome within each segment [27]. The following
linear regression model is specified to estimate the level
and trend in the dependent variable before accreditation
and the changes in level and trend following accreditation.
Y t ¼ β0 þ β1  timet þ β2  interventiont þ β3
 time after interventiont þ et
Where, Yt is the outcome, time t indicates time in
months at timet from the start of the observation period
to the last time point in series; intervention is a measure
for timet designated as a dummy variable taking the values
0 occurring before intervention and 1 after the interven-
tion (accreditation), which was implemented at month 12
in the series; time after intervention is a continuous vari-
able recording the number of months after the interven-
tion at timet, coded 0 before the accreditation and (time-
36) after the accreditation. In this model:
 β0 is the baseline level of the outcome at the
beginning of the series;
 β1 is the slope prior to accreditation (i.e. the baseline
trend);
 β2 is the change in level immediately after the
accreditation;
 β3 is the change in the slope from pre to post-
accreditation; the sum of β1 and β3 is the post-
intervention slope and
 et represents the random error term.
There are three particular characteristics of time-
series— auto-correlation, non-stationarity, and seasonalitywhich may lead to biased results [28]. The solutions to
these problems are outlined below.
Autocorrelation, non-stationarity and seasonality in time series
If the Durbin-Watson statistic for first-order autocorrel-
ation is significant, the model is adjusted by estimating
the autocorrelation parameter and including it in the
segmented regression model. Second, in order to establish
whether a given time series displays autocorrelation, it
is necessary to first render that series stationary. Non-
stationarity relates to the data exhibiting one or more nat-
ural trends, implying that the mean value and variance of
the data series can change over time for reasons exclusive
of the effect of the intervention [29]. Finally, seasonality
needs to be controlled since the pre-accreditation and
post-accreditation time periods contain different sea-
sonal profiles (e.g. more summer months in the post-
accreditation period), which could potentially distort the
actual effect of an intervention [28]. If the series displays
seasonality or some other non-stationary pattern, the
usual solution is to take the difference of the series from
one period to the next and then analyze this differenced
series. Sometimes a series may need to be differenced
more than once or differenced at lags greater than one
period. In order for seasonal autocorrelation terms to be
identified and estimated, it is necessary that the series does
not contain a seasonal unit root. Formal statistical testing
for the presence of unit roots in time series was conducted
using the Dickey-Fuller Test [30]. The series is stationary/
no seasonality if P < 0.05.
In order to render a series stationary, obtaining a con-
stant mean level of a series is achieved by removing any
apparent trend component contained in this series. There
are two general approaches to achieving this: (1) differen-
cing the series by subtracting from each time point t1 the
value of the previous time point t-1 or (2) de-trending the
series using a regression approach and working with the
model residuals. The Dickey-Fuller statistic [30] is used to
test for stationarity. In cases where the null hypothesis of a
unit root was rejected under this model, it was assumed
that the series did not require differencing. Where the null
hypothesis of a unit root is not rejected, then further ana-
lysis was done before concluding that differencing is re-
quired. This study uses a 48 month time series from the
period January 2009 to December 2012, sufficient to enable
detection and modelling of any seasonal patterns [31].
Results
Patient assessment measures
Table 2 displays the segmented regression equations of
the time series before and after accreditation for the
dependent variables of Initial Medical Assessments (Y1),
Initial Nursing Assessments (Y2), Pain Assessments (Y3),
and Pain Reassessments (Y4). Accreditation did not have a
Table 2 Patient assessment and laboratory safety measures
Model validation and parameter estimation Diagnostic tests
Patient assessment
measures
Intercept Time(β1) Intervention (β2) (Change in level) Tim_Aft_Int (β3) (Change in slope) R
2 Autocorrelation
(AC) Check
Test for Seasonality/
Stationarity
(Durbin Watson) (Dickey Fuller Unit
Root Test)
Value P-value Value P-value Coefficient 95% confidence
interval (LCI-UCI)
P-value Coefficient 95% confidence
interval (LCI-UCI)
P-value R2 D-Value
(before)
D-Value
(after)
P-value Result
Y1 78.60 0.00* 1.19 0.35 −4.54 (−16.33 to 7.25) 0.44 −0.99(−3.63 to 1.65) 0.45 0.38 1.00 1.92 0.03 No Seasonality
Y2 96.17 0.00* 0.13 0.53 1.24 (−1.63 to 4.11) 0.38 −0.18 (−0.60 to 0.24) 0.39 0.09 1.46 No AC 0.00 No Seasonality
Y3 94.56 0.00* 0.16 0.85 −4.00 (−12.10 to 4.10) 0.33 −0.02 (−1.82 to 1.77) 0.98 0.34 1.05 2.22 0.04 No Seasonality
Y4 32.56 0.00* 7.02 0.00* −13.91 (−32.37 to 4.56) 0.14 −7.28 (−10.00 to −4.56) 0.00* 0.48 1.72 No AC 0.00 No Seasonality
Laboratory safety measures
Y5 (in hours) 7.06 0.00* −0.36 0.00* 0.34(0.13, 0.54) 0.52 0.34(0.04, 0.64) 0.00* 0.73 1.31 2.11 0.04 No Seasonality
Y6 (minutes) 47.58 0.00* 0.15 0.46 −0.43(−2.99, 2.13) 0.74 −0.60(−1.02, −0.18) 0.01* 0.90 1.85 No AC 0.95 Data is not stationary
AC refers to Autocorrelation, D-Value is the Durbin Watson statistic, *P ≤ 0.05 is considered significant.
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sures of Y1, Y2 and Y3. Hospitals are mandated to publish
a four month track record of compliance prior or accredit-
ation (Joint Commission International, 2010) and thus the
results may be influenced in part by the high compliance
with the standard prior to the accreditation survey. Fur-
thermore, only one of the measures (percentage of com-
pleted pain reassessments) had a significant decrease in
the slope post accreditation survey. It also recorded a sig-
nificant pre-accreditation slope.
Laboratory safety measures
The outcome of analysis for the segmented regression
analysis for Timeliness of Complete Blood Count as a
Routine Lab Result (in hours) (Y5) and turnaround time
of Troponin Lab Results (minutes) (Y6) (Table 2) dem-
onstrated different results. The increase in Y5 measure
(turnaround time) immediately post- accreditation was not
significant but had a significant positive change in the slope
(P ≤ 0.0001) pre-accreditation and post-accreditation. Con-
versely, the Y6 measure (turnaround time) decreased
immediately post- accreditation survey with a significant
negative change in slope (P ≤ 0.0001). The positive Y6
measure results may be explained by the demand for
the laboratory results by the Emergency Department, a
process independent from accreditation. In addition,
the implementation of a clinical pathway on Acute
Myocardial Infarction requires the laboratory to improve
the turnaround time for Troponin as it is an important
decision making tool for clinicians.
Surgical procedures
There is a significant change in the level of the Y7 measure
(surgical procedure consent) after accreditation (P ≤ 0.01)
followed by a significant decrease in slope (Table 3).
The results may be attributed to the relatively high pre-
accreditation performance. Conversely, accreditation had
no significant impact on the operating room measures
Y8 (percentage cancellations of elective surgery) and Y9
(percentage return in OR within 48 hours).
Reported medication errors
The results in Table 3 demonstrate that immediately
following the accreditation survey, the level of reported
medication errors per 1000 prescriptions (Y10) dropped
significantly (P ≤ 0.001), but there was no significant
change in the slope after the intervention. A quality im-
provement project to reduce the number of medication
errors had been implemented in September 2009 (3 months
before the survey). Moreover, the JCI survey has a compre-
hensive approach (medication system tracer) to evaluate
compliance which may have led to the significant im-
provement. However, this improvement was not
sustained.Anesthesia and sedation measures
The accreditation survey was followed by a negative change
in level for five out of six measures, anesthesia and sedation
measures (Y11, Y12, Y14, Y15 and Y16), excludingY13, of which
four (Y11, Y12, Y14, and Y16) were significant (P ≤ 0.01)
(Table 4). Similarly, all six anesthesia measures demon-
strated a negative change in slope post-survey of which four
(Y11, Y12, Y14, and Y16) were significant (P ≤ 0.01). The nega-
tive change in post-accreditation slope is mainly due to staff
not sustaining the improvement, as there was no incentive
to do so due to the three year survey cycle.
Completion of the typed post-operative note within
48 hours
The results in Table 5 demonstrate an increase in the
level of Y17 measure but this was not significant. Con-
versely, the negative post-accreditation slope is significant
(P ≤ 0.01). These results reveal that improvement was
not sustained after accreditation, which may be due to
the relatively high existing compliance.
The infection control measures
Following the accreditation survey, the level of two out of
the three infection control measures increased (excluding
Y20) of which Y18 was significant (Y18), (P ≤ 0.05) (Table 5).
However all three measures exhibit an increase in the
slope post- survey of which Y18 is significant (P ≤ 0.05).
This may be partly attributed to a more developed in-
fection control programme and surveillance process after
the survey, thus resulting in the identification of more
infections.
Mortality rate
None of the coefficients for mortality rate Y21 is signifi-
cant (Table 5). This is largely due to the fact that the JCI
standards are more process and structure oriented and
thus would not impact on outcome measures. The stan-
dards do not address clinical care at a physician or practice
level.
International Patient Safety Goal (IPSG) Measures
Four out of the six patient safety goal measures recorded
an immediate decrease in level post-accreditation survey,
but only (Y23) was significant (Table 6). While five out of
the six measures recorded a negative change in the post-
accreditation slope, of which four (Y22, Y23, Y24 and Y27)
were significant. The purpose of the IPSGs is to high-
light problematic areas in health care and to promote
specific improvements in patient safety. These measures
are important to the organisation and thus the pre-
accreditation and overall performance was relatively
high. In addition, both the accreditation survey and imple-
mentation of the standards did not have a significant effect
Table 3 Surgical procedures and medication error use and near-misses
Model validation and parameter estimation Diagnostic tests
Surgical
Procedure
Measures
Intercept Time(β1) Intervention (β2)
(Change in level)
Tim_Aft_Int (β3)
(Change in slope)
R2 Autocorrelation (AC)
Check (Durbin Watson)
Test for Seasonality/Stationarity
(Dickey Fuller Unit Root Test)
Value P-value Value P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value D-Value
(before)
D-Value
(after)
P-value Result
Y7 87.91 0.00* 1.21 0.00* −2.70(−4.76, −0.63) 0.01* −1.18(−1.72, −0.64) 0.01* 0.96 1.30 2.53 0.00 No Seasonality
Y8 14.89 0.00* −0.28 0.38 −0.36(−4.66, 3.95) 0.87 0.32(−0.31, 0.95) 0.31 0.49 2.10 No AC 0.00 No Seasonality
Y9 0.08 0.5 0.003 0.88 −0.05(−0.30, 0.20) 0.69 0.01(−0.03, 0.04) 0.63 0.34 1.86 No AC 0.00 No Seasonality
Reported medication error measure
Y10 0.03 0.03* 0.002 0.21 −0.04(−0.06, −0.01) 0.00* −0.00(−0.01, 0.00) 0.18 0.35 1.56 No AC 0.00 No Seasonality
AC refers to Autocorrelation, D-Value is the Durbin Watson statistic, *P ≤ 0.05 is considered significant.
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Table 4 Anesthesia and sedation use measures
Model validation and parameter estimation Diagnostic tests
Anesthesia
and Sedation
Use Measures
Intercept Time(β1) Intervention (β2) (Change in level) Tim_Aft_Int (β3) (Change in slope) R
2 Autocorrelation (AC)
Check (Durbin Watson)
Test for Seasonality/
Stationarity (Dickey
Fuller Unit Root Test)
Value P-value Value P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value D-Value
(before)
D-Value
(after)
P-value Result
Y11 55.19 0.00* 5.02 0.00* −15.42(−23.38, −7.45) 0.00* −4.95(−6.12, −3.78) 0.00* 0.71 1.84 No AC 0.00 No Seasonality
Y12 28.87 0.00* 7.2 0.00* −7.17(−12.11, −2.23) 0.01* −7.30(−8.49, −6.11) 0.00* 0.81 2.84 1.91 1.00 Data is not
Stationary
Y13 92.15 0.000* 0.7 0.22 0.97(−4.86, 6.80) 0.74 −0.84(−1.98, 0.30) 0.14 0.33 1.27 1.91 0.02 No Seasonality
Y14 77.43 0.00* 2.61 0.00* −11.68(−20.04, −3.31) 0.01* −2.48(−4.07, −0.88) 0.00* 0.8 0.78 2.13 0.00 No Seasonality
Y15 97.01 0.000* 0.22 0.81 −6.17(−14.37, 2.03) 0.14 −0.02(−1.90, 1.87) 0.98 0.45 0.92 1.75 0.00 No Seasonality
Y16 67.2 0.00* 3.75 0.00* −12.83(−21.63, −4.03) 0.01* −3.64(−4.94, −2.35) 0.00* 0.53 1.76 No AC 0.00 No Seasonality
AC refers to Autocorrelation, D-Value is the Durbin Watson statistic, *P ≤ 0.05 is considered significant.
D
evkaran
and
O
’FarrellBM
C
H
ealth
Services
Research
 (2015) 15:137 
Page
8
of
14
Table 5 Infection control and content and use of patient records measures
Infection Control,
Surveillance and
Reporting Measures
Intercept Time(β1) Intervention (β2) (Change in level) Tim_Aft_Int (β3) (Change in Slope) R
2 Autocorrelation (AC)
Check (Durbin Watson)
Test for Seasonality/
Stationarity (Dickey
Fuller Unit Root Test)
Value P-value Value P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value D-Value
(before)
D-Value
(after)
P-value Result
Y18 6.90 0.00* -0.71 0.00* 1.41(0.09, 2.72) 0.04* 0.70(0.31, 1.100 0.001* 0.30 1.63 No AC 0.00 No Seasonality
Y19 0.65 0.22 -0.05 0.48 0.25(-0.81, 1.32) 0.63 0.08(-0.08, 0.23) 0.33 0.12 1.61 No AC 0.00 No Seasonality
Y20 0.08 0.50 0.00 1.00 -0.05(-0.29, 0.18) 0.64 0.00(-0.03, 0.04) 0.81 0.51 2.31 No AC 0.00 No Seasonality
Availability, Content and Use of Patient Records
Y17 57.33 0.000* 1.95 0.0058* 4.33(-4.98, 13.64) 0.35 -1.85(-3.22, -0.480 0.01* 0.54 1.75 No AC 0.01 No Seasonality
Mortality Rate
Y21 -0.04 0.59 0.02 0.15 -0.01(-0.16, 0.140 0.90 -0.02(-0.04, 0.01) 0.15 0.10 2 No AC 0.00 No Seasonality
AC refers to Autocorrelation, D-Value is the Durbin Watson statistic, *P ≤ 0.05 is considered significant.
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Table 6 International patient safety goals
Model validation and parameter estimation Diagnostic tests
International
Patient Safety
Goal Measures
Intercept Time(β1) Intervention (β2) (Change in Level) Tim_Aft_Int (β3) (Change in Slope) R
2 Autocorrelation (AC)
Check (Durbin Watson)
Test for Seasonality/
Stationarity (Dickey
Fuller Unit Root Test)
Value P-value Value P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value Coefficient 95%Confidence
Interval (LCI, UCI)
P-value D-Value
(before)
D-Value
(after)
P-value Result
Y22 40.56 0.000* 5.20 0.00* 0.79(−4.37, 5.94) 0.76 −5.269-6.19, −4.34) 0.00* 0.94 1.05 2.07 0.00 No Seasonality
Y23 25.70 0.000* 7.51 0.00* −14.89(−21.30, −8.49) 0.00* −7.36(−8.64, −6.08) 0.00* 0.90 1.1 2.43 0.14 Seasonality
Y24 91.94 0.000* 0.65 0.00* 0.21(−2.46, 2.89) 0.87 −0.67(−1.07, −0.28) 0.00* 0.42 1.96 No AC 0.00 No Seasonality
Y25 −0.02 0.96 0.02 0.71 0.14(−0.43, 0.71) 0.62 −0.02(−0.11, 0.06) 0.62 0.03 1.72 No AC 0.00 No Seasonality
Y26 98.48 0.00* −0.10 0.1 1.71(1.04, 2.38) 0.00* 0.11(0.00, 0.230) 0.06 0.52 2.86 2.03 0.06 Data Not
Stationary
Y27 55.51 0.00* 55.51 0.00* −1.67(−6.29, 2.96) 0.47 −4.26(−5.30, −3.22) 0.00* 0.90 0.89 2.6 0.26 No Seasonality
AC refers to Autocorrelation, D-Value is the Durbin Watson statistic, *P ≤ 0.05 is considered significant.
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gery practice prior to these interventions.
The above effects may be attributed to three factors.
First, surgical safety was considered an organisational pri-
ority and thus a Failure Modes Effects Analysis (FMEA)
was conducted as a quality improvement project. This re-
quired that the surgical team review the surgical safety
process and the potential areas of failure. An action plan
was formulated to circumvent error prone processes and
the JCI Universal protocol for safe surgery was imple-
mented in July 2009. Second, JCI considers surgical safety
and the universal protocol as an International Patient
Safety Goal. Organisations that fail this standard, fail the
entire accreditation survey. Finally, surgery on the in-
correct patient, site or side is known as a sentinel event.
The repercussions for the organisation are serious and
mandate reporting to JCI and HAAD, which, may result
in unfavorable publicity that would adversely affect the
reputation of the hospital. Most importantly, wrong site
surgery may cause permanent harm or death in a patient.
Impact of the accreditation survey (December 2009) on
the 27 quality measures
1. From the analysis, 20 of the 27 (74%) measures
display a positive pre-accreditation slope of which
thirteen (48%) are statistically significant (P ≤ 0.05).
2. A key finding is that accreditation had no significant
impact (either positive or negative) on 11 out of the
27 measures.
3. The accreditation survey resulted in a significant
positive change in level for only 2 (7%) of the
measures (medication errors and hand hygiene
compliance). Conversely, a significant negative
change in level was observed in 7 (26%) of the
measures.0
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Figure 1 Time Series Graph of the percentage of compliance before a
following quality measures were used to create this time series graph: Y1, Y2, Y3
survey which occurred in December 2009.4. Only 1 measure (4%), (Troponin turnaround time)
resulted in a significant positive change in the
post-accreditation slope.
5. Accreditation was associated with a significant
negative change in slope in 13 (48%) of the measures.
6. Of the 27 quality measures, there is no significant
positive change in the level of 25 measures post-
accreditation. Additionally, there was no significant
positive change in the slope of 26 measures post-
accreditation.
Discussion
Accreditation resulted more frequently in a significant
negative change in level (7 measures) than a positive
change in level (2 measures) after the survey. Moreover,
accreditation had a much larger significant negative ef-
fect (48% of measures) than a positive effect (4%) on the
slope. Even though the organisation had no significant
changes in structure or service lines, and the same Quality
Manager was employed for the entire period of obser-
vation, accreditation improvement proved difficult to
sustain. Continuous survey readiness is fundamental and
thus a policy of unannounced surveys may well enhance
performance improvement. Frequent internal or external
surveys may also encourage organisations to maintain the
process of improvement. In addition, since many of the
measures had existing high values pre-accreditation, any
improvement in the performance may have been too small
to be statistically significant.
Figure 1 illustrates the pattern of accreditation compli-
ance using quality measures. The hospital ramps up its per-
formance prior to the survey. There is a sharp incline
in the pre-accreditation slope with an immediate drop
post-accreditation survey. This is followed by an undulating
plateau in performance during the three year period. The
results demonstrate that once the accreditation survey isEstimates
Mean
0*             0.00* 0.00*                           
nd after the accreditation survey. Note: the average means of the
, Y4, Y7, Y11- Y17, Y22- Y25, Y27. The red arrow demarcates the Accreditation
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formance plateaus. However, the figure shows that there is
residual benefit from accreditation three years later with
performance maintained at approximately 90%, which is 20
percentage points higher than the baseline level in 2009.
It can be argued that the on-site evaluation during an
accreditation survey might only be seen as an organisa-
tional snapshot on the given day of the survey and thus
all accreditation systems suffer from the potential criti-
cism that their impact ends following completion of the
survey. In order to sustain their value, there is a need to
encourage participants to continue to maintain perceive
benefits from the standards. This is not only in line with
the models of continuous quality improvement; it also
makes good commercial sense [32]. Limited life expect-
ancy of the accreditation status is a way to deal with this.
It can be argued that the standards are not ‘sensitive’
enough to allow the possibility of actually evaluating im-
provements. This is based on the fact that it has been
found by other accreditation organisations that several in-
stitutions already comply with the accreditation standards
the first time around, and therefore based on the way that
the standards are formulated, an improvement of quality
by an organisations does not necessarily lead to receiving
a higher degree of compliance of the standards because
the organisation has already fully complied with them.
This is largely because the standards are maximum
achievable across all types of hospitals independent of
their complexity and service lines. In addition, the pass/
fail concept does not drive performance beyond achieving
compliance with standards. Thus excellent organisations
that already comply with the standards are not incentiv-
ized by the accreditation process to improve their level of
performance. So, although a thorough accreditation sur-
vey is designed to help draw conclusions about the overall
quality and capability of an organisation, it is important to
recognize that this triennial snapshot is no substitute for
ongoing monitoring. Strategies are as a result required to
reinforce the way accreditation might lead to improved
quality of care. In recent times, alternative approaches
used by The Joint Commission, in the United States, such
as unannounced surveys and tracking patients with tracer
methodologies along their path through a healthcare or-
ganisation, from pre-entry to discharge, are designed to
help bring about improvements in accreditation processes
and organisational and clinical systems, but these are all
relatively untested [33].
Recommendations
Benchmarking of accredited organisations’ by the accredit-
ing body and submission of quality measures to a data li-
brary will ensure improvement between surveys. At the
time of writing, JCI does not have a data library for bench-
marking of accredited organisations. Benchmarking allowssharing of best practices and holds organisations account-
able for maintaining good performance. Creating a library
of mandatory reporting measures that are shared pub-
licly or with other internationally accredited organisations
would improve performance [34]. In recent times, health-
care organisations have begun focusing on the measure-
ment of clinical effectiveness. Thus, in order demonstrate
the efficacy of treatments, appropriate outcome measures
were sought to assist in policy and management decisions
about the appropriateness and the selection of clinical
treatment. In addition, reliable and valid clinical outcome
measures would answer the fundamental question of
whether accreditation and compliance to its standards,
has a causal relationship with patient outcomes.
JCI has no intra-cycle survey or periodic assessments
between the survey periods. The Joint Commission in
the US has established the expectation of continual readi-
ness with the implementation of the unannounced survey
in 2009. The Periodic Performance Review is also a Joint
Commission annual requirement. Organisations assess
their level of compliance for each standard and element of
performance. This self-assessment forms the basis of the
improvement efforts for gaps in compliance [35]. How-
ever, these self-assessments are not mandated by JCI. It is
recommended that there should be a shift in the ac-
creditation inspection process from a scheduled to un-
scheduled survey which will result in a change from a
survey preparation mindset to that of continual readiness.
The accreditation standards largely review processes of
care and not clinical outcomes. A crucial issue with the
choice of implementing an accreditation model is ultim-
ately whether accreditation even ensures quality, or has
positive effects on the quality of care delivered by the
accredited organisations. Achieving accreditation is typic-
ally regarded as a predictor of clinical care and organisa-
tional effectiveness by funders, institutions, patients and
the public. This is meant to create confidence in the qual-
ity of care provided by an organisation. However, there is
no real guarantee that an organisation which is well
assessed during the accreditation process will always pro-
vide high quality care [36]. Accreditation only guarantees
that the organisation meets standards which are deemed
necessary by the accreditation organisation. Thus, al-
though we are living in an increasingly evidence-based
world, there has been little concrete evidence about the
impact that individual accreditation programmes have on
the healthcare system, healthcare providers and other
stakeholders [5]. Similar to this study, there is evidence
that hospitals rapidly increase compliance with the ac-
creditation standards and improve their organisational
processes in the months prior to the surveys, but there is
still much less evidence that this brings benefits to the
clinical process and the outcome of the healthcare sys-
tems [5,37].
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limitations. The study is based on a single hospital.
However, such an approach has one major advantage:
focusing upon one hospital provides a controlled envir-
onment, which is necessary for the time series method-
ology and permitted the researchers to attribute changes
in the quality measures to the intervention of accredit-
ation. Additionally, the use of primary data, the large sam-
ple size (over 12,000 patient records were reviewed), the
variation and large number of quality measures (27 mea-
sures covering various dimensions of quality), the length
of the study period and the number of observations
(324,000 observations) compensates for this limitation.
The study is set in resource- rich UAE and thus cannot
be compared to developing countries. Nonetheless, the
study evaluated international accreditation, which is a
voluntary process and applied in many parts of the
world. The researchers recommend that the validity of
this study is tested in other settings. Only 7 out of the
27 measures were outcome measures. This is primarily
because the study objective was to evaluate compliance
and thus measures were linked to a specific standard.
The challenge with the inclusion of outcome measures
is to isolate the change in the measure due to accredit-
ation and not for example, the disease process, comor-
bidities, the competence of the healthcare professional
and other contributing factors. Further research is rec-
ommended to determine the impact of accreditation on
patient outcomes.
Conclusion
The most commonly used approach to evaluating accredit-
ation systems has been a perception of benefits approach,
which allows individuals to record their interpretations
of improvements in the quality of service, changes in
practices and their satisfaction with the process. Al-
though perceived benefits are important in determining
the acceptability of the accreditation process, they do
not demonstrate that any change has taken place in the
delivery of healthcare [32]. Whilst many postulations
about the benefits of accreditation processes exist, em-
pirical evidence to prove those claims is still currently
lacking. According to Greenfield and Braithwaite [18]
the fact that the empirical evidence base for accreditation,
remains substantially undeveloped, creates a significant
validity challenge for accreditation providers, policy-
makers and researchers. Achieving and maintaining an ac-
creditation status requires a significant investment of
resources, and for many organisations, the cost-
effectiveness is debatable, including whether or not ac-
creditation demonstrates a quantifiable improvement in
healthcare delivery and outcomes [14]. Many countries
are embarking on accreditation programs without any
evidence about their effectiveness [5]. Nevertheless,without an empirically grounded, comprehensive evi-
dence base for accreditation, the varying positive and
negative views about accreditation will remain anecdotal
and influenced by ideology or preferences [13]. There-
fore, this is the first study that uses time series analysis
over a 4-year period to demonstrate the impact of ac-
creditation on quality measures. In addition, the study
makes recommendations on the fundamental components
of an accreditation program required to mitigate this ef-
fect and sustain improvement. It is argued that the imple-
mentation of standards combined with an external
survey is no guarantee for continuous improvement.
There needs to be a paradigm change from that of a snap-
shot review to a continual assessment [37]. Accreditation
can make a contribution to business improvement but if
used incorrectly it can result in a bureaucratic system that
is complex to sustain and engage staff. The study shows
that while accreditation has residual benefit three years
later, continuous survey readiness, frequent self-
assessment, frequent external review and other con-
tinuous quality improvement methods are necessary to
sustain the positive impact of accreditation.
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